Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06441435
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-04
First Post:
2024-05-21
Brief Title:
The Effect of AC-134 in Chronic Kidney Diseases
Sponsor:
Taichung Veterans General Hospital
Organization:
Taichung Veterans General Hospital
Study Overview
Official Title:
To Investigate the Protective Effect of AC 134 in Chronic Kidney Diseases
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective is to explore the effects of adding AC-134 on renal function proteinuria uremic toxins and metabolism-related markers in chronic kidney disease
Detailed Description:
Chronic kidney disease CKD management primarily focuses on addressing associated complications such as hypertension diabetes mellitus cardiovascular disease and proteinuria In addition to standard therapies reducing the accumulation of toxins particularly gut-derived uremic toxins like indoxyl sulfate IS and p-cresol sulfate PCS may help alleviate uremia symptoms This study assesses the impact of oral AC-134 capsules containing activated charcoal adsorbent on CKD patients The assessment will include evaluating changes in renal function proteinuria uremic toxins and metabolism-related markers
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None